Skip to main content
. 2018 Mar 14;26(5):248–252. doi: 10.1136/ejhpharm-2017-001344

Table 3.

Characteristics of non-ST segment elevation myocardial infarction in phase 1 and phase 2, before and after propensity score matching

Characteristic Before PSM After PSM
Phase 1
(n (%))
Phase 2
(n (%))
Phase 1
(n (%))
Phase 2
(n (%))
(n=407) (n=2015) (n=407) (n=407)
Age (years) 65.5±11.5 65.4±10.2 65.5±11.5 64.6±10.2
Men 299 (73.5) 1475 (73.2) 299 (73.5) 295 (72.5)
Women 108 (26.5) 540 (26.8) 108 (26.5) 112 (27.5)
CCI (%)
 0 198 (48.6) 995 (49.4) 198 (48.6) 213 (52.3)
 1 130 (31.9) 616 (30.6) 130 (31.9) 115 (28.2)
 2 54 (13.3) 230 (11.4) 54 (13.3) 47 (11.5)
 3 19 (4.7) 104 (5.2) 19 (4.7) 20 (4.9)
 ≥4 6 (1.5) 70 (3.5)* 6 (1.5) 12 (2.9)

*P<0.05.

CCI, Charlson Comorbidity Index, PSM, propensity score matching.